Imbria Pharmaceuticals Announces Publication of IMPROVE-DiCE Phase 2a Data in Circulation, Demonstrating Ninerafaxstat as a Potential First-in-Class Therapy Targeting Cardiac ...

Data provide first human validation of cardiac energetics modulation as a therapeutic target in cardiometabolic heart disease, including heart ...
Healio

mRNA technology may have potential to repair, regenerate cardiac tissue

Please provide your email address to receive an email when new articles are posted on . Tissue regeneration has been achieved in certain parts of the body, but not the heart. That could change if a ...
EurekAlert!

NSUN2: a key player in cardiac hypertrophy and heart failure

A new study published in Engineering reveals that NSUN2, a key protein involved in RNA modification, significantly ...
The Manila Times

Lexeo Therapeutics Announces Research Collaboration to Explore Targeted Cardiac Delivery of AAV Gene Therapy

Collaboration will combine Lexeo expertise in cardiac genetic medicine with Johnson & Johnson’s expertise in cardiovascular ...
News-Medical.Net on MSN

Study sheds new light on the role of NSUN2 protein in cardiac hypertrophy and heart failure

A recent study published in Engineering has shed new light on the role of the protein NSUN2 in the development of cardiac ...
Science Daily

Cardiac muscle really knows how to relax: Potential cardio-protective mechanism in heart

New insight into the physiology of cardiac muscle may lead to the development of therapeutic strategies that exploit an inherent protective state of the heart. The research discovers a state of ...
technologynetworks

Electrophysiology Fundamentals, Membrane Potential and Electrophysiological Techniques

This article focuses on single-cell electrophysiology and introduces the fundamentals of electrophysiological investigation by describing the ionic basis of action potentials and the different ...